Brenda M Birmann

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study
    Brenda M Birmann
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115
    Cancer Prev Res (Phila) 7:33-41. 2014
  2. pmc Body mass index, physical activity, and risk of multiple myeloma
    Brenda M Birmann
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 16:1474-8. 2007
  3. pmc Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica
    Brenda M Birmann
    Department of Epidemiology, Brigham and Women s Hospital and Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 124:614-21. 2009
  4. pmc Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma
    Brenda M Birmann
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 18:282-8. 2009
  5. pmc A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma
    Kimberly A Bertrand
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Prev Res (Phila) 6:864-73. 2013
  6. ncbi Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I
    Brenda M Birmann
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    J Med Virol 78:847-52. 2006
  7. pmc Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women
    Eva S Schernhammer
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Am J Clin Nutr 96:1419-28. 2012
  8. ncbi Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults
    Brenda M Birmann
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 13:1385-91. 2004
  9. pmc Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study
    Julie L Kasperzyk
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
    Am J Epidemiol 174:816-27. 2011
  10. pmc A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma
    Kimberly A Bertrand
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA
    Blood 116:3547-53. 2010

Detail Information

Publications14

  1. pmc Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study
    Brenda M Birmann
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115
    Cancer Prev Res (Phila) 7:33-41. 2014
    ..e., NF-κB- or COX-2 mediated) pathways. The utility of aspirin for multiple myeloma chemoprevention warrants further evaluation...
  2. pmc Body mass index, physical activity, and risk of multiple myeloma
    Brenda M Birmann
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 16:1474-8. 2007
    ..In conclusion, obesity seems to have an etiologic role in multiple myeloma, but the role of other correlates of energy balance remains uncertain...
  3. pmc Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica
    Brenda M Birmann
    Department of Epidemiology, Brigham and Women s Hospital and Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 124:614-21. 2009
    ....
  4. pmc Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma
    Brenda M Birmann
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 18:282-8. 2009
    ..Nonetheless, the data are consistent with the hypothesis that IGF-1- and IL-6-related gene variation influences susceptibility to multiple myeloma and warrant confirmation in larger populations...
  5. pmc A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma
    Kimberly A Bertrand
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Prev Res (Phila) 6:864-73. 2013
    ..01). These findings in two large prospective cohorts provide novel evidence that larger body size in childhood, adolescence, and young adulthood predicts increased risk of NHL, and particularly of DLBCL and follicular lymphoma...
  6. ncbi Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I
    Brenda M Birmann
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    J Med Virol 78:847-52. 2006
    ....
  7. pmc Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women
    Eva S Schernhammer
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Am J Clin Nutr 96:1419-28. 2012
    ..Despite safety reports of the artificial sweetener aspartame, health-related concerns remain...
  8. ncbi Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults
    Brenda M Birmann
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 13:1385-91. 2004
    ..We conclude that, with the exception of soluble CD30, the serologic markers are informative for the characterization of type 1/type 2 immune status using archived sera from study populations of healthy adults...
  9. pmc Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study
    Julie L Kasperzyk
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
    Am J Epidemiol 174:816-27. 2011
    ..Associations between diet and risk of Epstein-Barr virus-negative disease require confirmation in other populations...
  10. pmc A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma
    Kimberly A Bertrand
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA
    Blood 116:3547-53. 2010
    ..Overall, we found no evidence that EBV antibody profile predicts NHL risk in immunocompetent persons, with the possible exception of chronic lymphocytic leukemia/small lymphocytic lymphoma...
  11. pmc Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium
    Brenda M Birmann
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Blood 120:4929-37. 2012
    ....
  12. pmc Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis
    Nancy E Mueller
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 130:2886-91. 2012
    ..EBNA antibodies were not significantly associated with IM history in HL cases or siblings. These associations suggest that chronic or more severe EBV infection is a risk factor for HL, independent of IM history...
  13. pmc Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic
    Brenda M Birmann
    Brenda M Birmann, Ying Bao, Marta Crous Bou, Immaculata De Vivo, and Shelley S Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA Mollie E Barnard is with the Department of Epidemiology, Harvard T H Chan School of Public Health, Boston Kimberly A Bertrand is with the Slone Epidemiology Center, Boston University, Boston Brian M Wolpin is with the Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School
    Am J Public Health 106:1608-15. 2016
    ..To review the contributions of the Nurses' Health Study (NHS) to epidemiologic knowledge of endometrial, ovarian, pancreatic, and hematologic cancers...
  14. pmc Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men
    Mara M Epstein
    Authors Affiliations Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts UCLA AIDS Institute, and Departments of Psychiatry and Biobehavioral Sciences and Obstetrics and Gynecology, David Geffen School of Medicine at UCLA Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania Department of Medicine Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois Departments of Molecular Microbiology and Immunology and Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland Department of Microbiology, Immunology and Molecular Genetics, and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California
    Cancer Epidemiol Biomarkers Prev 22:2009-15. 2013
    ..Estimates of the within-person temporal stability of serum markers partly assess the utility of single biomarker measurements and may have important implications for the design of prospective studies of chronic disease risk...